• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
No Result
View All Result
Tuesday, January 31, 2023
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
No Result
View All Result
Alternatives Watch
No Result
View All Result

NovaQuest hits hard cap in latest fund

Susan BarretobySusan Barreto
May 13, 2022
in Manager News, Private Equity
NovaQuest hits hard cap in latest fund

By Rawpixel

ShareTweetShareSendSend

NovaQuest Private Equity held the final close of its second fund at $500 million after less than seven months of fundraising.

Like the firm’s preceding fund that started to deploy capital 2018, NovaQuest Private Equity Fund II is managed by partners Vern Davenport, Jeff Edwards Ashton Pool and Michael Sorensen. The firm’s focus on pharmaceutical companies has contributed greatly to its IRR, with a distinct focus on late stages of R&D and commercialization, according to an interview with CIO Jonathan Tunnicliffe last year.

“As a continuation of the strategy we executed in our first fund, NQPE II will focus on investing in innovative companies in attractive thematic sectors and on partnering with talented management teams to build great companies,” said Sorenson in a statement. Following the fund close, NovaQuest assets now total approximately $1.2 billion of assets and has completed seven active platform investments and 11 additional acquisitions.

The fund strategy relies on the firm’s vast strategic network, including the affiliated fund strategy NovaQuest Product Finance, to invest in tech-enabled life sciences and pharmaceutical services companies that improve outcomes and reduce the overall cost of care. The team targets lower middle market companies and uses its own in-house operating expertise to drive operational improvements and to prepare companies for growth.

Previous NQPE investments include Azurity Pharmaceuticals, a leading provider of drug delivery technology solutions; Clinical Ink, a provider of eClinical data collection technology; and Catalyst Clinical Research, a provider of outsourced clinical services for clinical trials.

Eaton Partners served as the placement agent for NQPE II and Ropes & Gray LLP provided legal counsel.

ShareTweetShareSendSend
Previous Post

ADDX exchange tokenizes Temasek-backed private equity FoFs

Next Post

Carlyle builds new energy transition infrastructure platform

Related Posts

NY pension adds $1.2bn across PE, credit, HF and real estate programs
Pensions

NY pension adds $1.2bn across PE, credit, HF and real estate programs

Texas fund allocates $90m to private markets, reviews annual plan
Pensions

Texas fund allocates $90m to private markets, reviews annual plan

NJ DOI invests with existing alts managers
Pensions

NJ DOI invests with existing alts managers

Vidrio expands Qontigo partnership with portfolio and risk enhancements
Hedge Funds

Vidrio expands Qontigo partnership with portfolio and risk enhancements

NEA raises $6.2bn across two tech and healthcare funds
Manager News

NEA raises $6.2bn across two tech and healthcare funds

Next Post
Carlyle builds new energy transition infrastructure platform

Carlyle builds new energy transition infrastructure platform

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Atalaya closes special opportunities fund at $1.8bn

Atalaya closes special opportunities fund at $1.8bn

NY pension adds $1.2bn across PE, credit, HF and real estate programs

NY pension adds $1.2bn across PE, credit, HF and real estate programs

Bridge collects $2.26bn for multifamily housing

Bridge collects $2.26bn for multifamily housing

AI hedge fund Castle Ridge builds success with multi-model system

AI hedge fund Castle Ridge builds success with multi-model system

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research
  • Subscribe
  • Log In

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In

© 2019-2022, All Rights Reserved  |  BMV Digital

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

Cookie Consent
We do not use cookies on our website other than those that are strictly necessary for the website to function. By clicking “Accept”, you consent to the use of all six strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo